STOCK TITAN
  1. Home
  2. Sec-filings
  3. CON
  4. [Form 4] Concentra Group Holdings Parent, Inc. Insider Trading Activity

CON Form 4: Director receives two RS grants totaling 15,496

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. (CON) reported a director equity award on a Form 4. On 11/04/2025, the director acquired 15,496 shares of common stock via two restricted stock grants at a stated price of $0.

One grant covered 7,748 shares that vest in equal annual installments over five years. A second grant covered 7,748 shares that, subject to certain exceptions, vest in full on November 4, 2026, the first anniversary of the grant date. Following these grants, the Form 4 shows 15,496 shares beneficially owned directly.

Positive

  • None.

Negative

  • None.
Insider Bonner Brigid A.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 7,748 $0.00 --
Grant/Award Common Stock 7,748 $0.00 --
Holdings After Transaction: Common Stock — 7,748 shares (Direct)
Footnotes (1)
  1. Grant of restricted stock which will vest in equal annual installments over five years. Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bonner Brigid A.
(Last) (First) (Middle)
C/O CONCENTRA GROUP HOLDINGS PARENT, INC
5080 SPECTRUM DRIVE, SUITE 1200W
(Street)
ADDISON TX 75001
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/04/2025 A(1) 7,748 A $0 7,748 D
Common Stock 11/04/2025 A(2) 7,748 A $0 15,496 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock which will vest in equal annual installments over five years.
2. Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date.
/s/ Timothy F. Ryan, Attorney-in-Fact 11/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Concentra (CON) disclose in this Form 4?

A director received restricted stock awards totaling 15,496 common shares on 11/04/2025.

How many shares were in each restricted stock grant for CON?

Two grants of 7,748 shares each, totaling 15,496 shares.

What are the vesting terms of the director’s CON stock grants?

One grant vests in equal annual installments over five years; the other vests in full on November 4, 2026, subject to certain exceptions.

What is the transaction price listed for the CON grants?

The Form 4 lists a price of $0 for both restricted stock acquisitions.

How many CON shares does the director beneficially own after the transactions?

The filing reports 15,496 shares beneficially owned directly after the grants.

What is the reporting person’s relationship to CON?

The reporting person is a Director of Concentra Group Holdings Parent, Inc.